Global Gene-based Therapy Medicinal Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Gene-based Therapy Medicinal market size was valued at US$ 8866.4 million in 2022. With growing demand in downstream market, the Gene-based Therapy Medicinal is forecast to a readjusted size of US$ 47170 million by 2029 with a CAGR of 27.0% during review period.
The research report highlights the growth potential of the global Gene-based Therapy Medicinal market. Gene-based Therapy Medicinal are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Gene-based Therapy Medicinal. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Gene-based Therapy Medicinal market.
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The gene-based therapy medicinal market is driven by the potential for revolutionary treatments by targeting genetic disorders at their source. These therapies offer hope for conditions with no existing cures. However, a significant challenge is the complexity of gene-based therapies and the need for rigorous clinical trials to prove safety and efficacy. Regulatory approvals and high development costs pose challenges for manufacturers. Additionally, market competition and pricing concerns necessitate a balance between accessibility and recovering research and development investments. The gene-based therapy market holds promise but faces hurdles in delivering groundbreaking treatments while addressing scientific, regulatory, and economic challenges.
Key Features:
The report on Gene-based Therapy Medicinal market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Gene-based Therapy Medicinal market. It may include historical data, market segmentation by Type (e.g., Viral Gene Delivery System, Non-viral Gene Delivery System), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Gene-based Therapy Medicinal market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Gene-based Therapy Medicinal market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Gene-based Therapy Medicinal industry. This include advancements in Gene-based Therapy Medicinal technology, Gene-based Therapy Medicinal new entrants, Gene-based Therapy Medicinal new investment, and other innovations that are shaping the future of Gene-based Therapy Medicinal.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Gene-based Therapy Medicinal market. It includes factors influencing customer ' purchasing decisions, preferences for Gene-based Therapy Medicinal product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Gene-based Therapy Medicinal market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Gene-based Therapy Medicinal market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Gene-based Therapy Medicinal market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Gene-based Therapy Medicinal industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Gene-based Therapy Medicinal market.
Market Segmentation:
Gene-based Therapy Medicinal market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Gene-based Therapy Medicinal market size was valued at US$ 8866.4 million in 2022. With growing demand in downstream market, the Gene-based Therapy Medicinal is forecast to a readjusted size of US$ 47170 million by 2029 with a CAGR of 27.0% during review period.
The research report highlights the growth potential of the global Gene-based Therapy Medicinal market. Gene-based Therapy Medicinal are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Gene-based Therapy Medicinal. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Gene-based Therapy Medicinal market.
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The gene-based therapy medicinal market is driven by the potential for revolutionary treatments by targeting genetic disorders at their source. These therapies offer hope for conditions with no existing cures. However, a significant challenge is the complexity of gene-based therapies and the need for rigorous clinical trials to prove safety and efficacy. Regulatory approvals and high development costs pose challenges for manufacturers. Additionally, market competition and pricing concerns necessitate a balance between accessibility and recovering research and development investments. The gene-based therapy market holds promise but faces hurdles in delivering groundbreaking treatments while addressing scientific, regulatory, and economic challenges.
Key Features:
The report on Gene-based Therapy Medicinal market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Gene-based Therapy Medicinal market. It may include historical data, market segmentation by Type (e.g., Viral Gene Delivery System, Non-viral Gene Delivery System), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Gene-based Therapy Medicinal market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Gene-based Therapy Medicinal market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Gene-based Therapy Medicinal industry. This include advancements in Gene-based Therapy Medicinal technology, Gene-based Therapy Medicinal new entrants, Gene-based Therapy Medicinal new investment, and other innovations that are shaping the future of Gene-based Therapy Medicinal.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Gene-based Therapy Medicinal market. It includes factors influencing customer ' purchasing decisions, preferences for Gene-based Therapy Medicinal product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Gene-based Therapy Medicinal market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Gene-based Therapy Medicinal market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Gene-based Therapy Medicinal market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Gene-based Therapy Medicinal industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Gene-based Therapy Medicinal market.
Market Segmentation:
Gene-based Therapy Medicinal market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Viral Gene Delivery System
- Non-viral Gene Delivery System
- Neurological Diseases
- Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Biogen
- Novartis
- Gilead Sciences
- Sarepta Therapeutics
- Alnylam Pharmaceuticals
- Amgen
- Spark Therapeutics
- Akcea Therapeutics
- Sunway Biotech
- SIBIONO
- AnGes
- Orchard Therapeutics
- Human Stem Cells Institute
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene-based Therapy Medicinal Market Size 2018-2029
2.1.2 Gene-based Therapy Medicinal Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Gene-based Therapy Medicinal Segment by Type
2.2.1 Viral Gene Delivery System
2.2.2 Non-viral Gene Delivery System
2.3 Gene-based Therapy Medicinal Market Size by Type
2.3.1 Gene-based Therapy Medicinal Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Gene-based Therapy Medicinal Market Size Market Share by Type (2018-2023)
2.4 Gene-based Therapy Medicinal Segment by Application
2.4.1 Neurological Diseases
2.4.2 Cancer
2.4.3 Other
2.5 Gene-based Therapy Medicinal Market Size by Application
2.5.1 Gene-based Therapy Medicinal Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Gene-based Therapy Medicinal Market Size Market Share by Application (2018-2023)
3 GENE-BASED THERAPY MEDICINAL MARKET SIZE BY PLAYER
3.1 Gene-based Therapy Medicinal Market Size Market Share by Players
3.1.1 Global Gene-based Therapy Medicinal Revenue by Players (2018-2023)
3.1.2 Global Gene-based Therapy Medicinal Revenue Market Share by Players (2018-2023)
3.2 Global Gene-based Therapy Medicinal Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE-BASED THERAPY MEDICINAL BY REGIONS
4.1 Gene-based Therapy Medicinal Market Size by Regions (2018-2023)
4.2 Americas Gene-based Therapy Medicinal Market Size Growth (2018-2023)
4.3 APAC Gene-based Therapy Medicinal Market Size Growth (2018-2023)
4.4 Europe Gene-based Therapy Medicinal Market Size Growth (2018-2023)
4.5 Middle East & Africa Gene-based Therapy Medicinal Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Gene-based Therapy Medicinal Market Size by Country (2018-2023)
5.2 Americas Gene-based Therapy Medicinal Market Size by Type (2018-2023)
5.3 Americas Gene-based Therapy Medicinal Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene-based Therapy Medicinal Market Size by Region (2018-2023)
6.2 APAC Gene-based Therapy Medicinal Market Size by Type (2018-2023)
6.3 APAC Gene-based Therapy Medicinal Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene-based Therapy Medicinal by Country (2018-2023)
7.2 Europe Gene-based Therapy Medicinal Market Size by Type (2018-2023)
7.3 Europe Gene-based Therapy Medicinal Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene-based Therapy Medicinal by Region (2018-2023)
8.2 Middle East & Africa Gene-based Therapy Medicinal Market Size by Type (2018-2023)
8.3 Middle East & Africa Gene-based Therapy Medicinal Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE-BASED THERAPY MEDICINAL MARKET FORECAST
10.1 Global Gene-based Therapy Medicinal Forecast by Regions (2024-2029)
10.1.1 Global Gene-based Therapy Medicinal Forecast by Regions (2024-2029)
10.1.2 Americas Gene-based Therapy Medicinal Forecast
10.1.3 APAC Gene-based Therapy Medicinal Forecast
10.1.4 Europe Gene-based Therapy Medicinal Forecast
10.1.5 Middle East & Africa Gene-based Therapy Medicinal Forecast
10.2 Americas Gene-based Therapy Medicinal Forecast by Country (2024-2029)
10.2.1 United States Gene-based Therapy Medicinal Market Forecast
10.2.2 Canada Gene-based Therapy Medicinal Market Forecast
10.2.3 Mexico Gene-based Therapy Medicinal Market Forecast
10.2.4 Brazil Gene-based Therapy Medicinal Market Forecast
10.3 APAC Gene-based Therapy Medicinal Forecast by Region (2024-2029)
10.3.1 China Gene-based Therapy Medicinal Market Forecast
10.3.2 Japan Gene-based Therapy Medicinal Market Forecast
10.3.3 Korea Gene-based Therapy Medicinal Market Forecast
10.3.4 Southeast Asia Gene-based Therapy Medicinal Market Forecast
10.3.5 India Gene-based Therapy Medicinal Market Forecast
10.3.6 Australia Gene-based Therapy Medicinal Market Forecast
10.4 Europe Gene-based Therapy Medicinal Forecast by Country (2024-2029)
10.4.1 Germany Gene-based Therapy Medicinal Market Forecast
10.4.2 France Gene-based Therapy Medicinal Market Forecast
10.4.3 UK Gene-based Therapy Medicinal Market Forecast
10.4.4 Italy Gene-based Therapy Medicinal Market Forecast
10.4.5 Russia Gene-based Therapy Medicinal Market Forecast
10.5 Middle East & Africa Gene-based Therapy Medicinal Forecast by Region (2024-2029)
10.5.1 Egypt Gene-based Therapy Medicinal Market Forecast
10.5.2 South Africa Gene-based Therapy Medicinal Market Forecast
10.5.3 Israel Gene-based Therapy Medicinal Market Forecast
10.5.4 Turkey Gene-based Therapy Medicinal Market Forecast
10.5.5 GCC Countries Gene-based Therapy Medicinal Market Forecast
10.6 Global Gene-based Therapy Medicinal Forecast by Type (2024-2029)
10.7 Global Gene-based Therapy Medicinal Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Gene-based Therapy Medicinal Product Offered
11.1.3 Biogen Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Biogen Main Business Overview
11.1.5 Biogen Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Gene-based Therapy Medicinal Product Offered
11.2.3 Novartis Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Information
11.3.2 Gilead Sciences Gene-based Therapy Medicinal Product Offered
11.3.3 Gilead Sciences Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Gilead Sciences Main Business Overview
11.3.5 Gilead Sciences Latest Developments
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Information
11.4.2 Sarepta Therapeutics Gene-based Therapy Medicinal Product Offered
11.4.3 Sarepta Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Sarepta Therapeutics Main Business Overview
11.4.5 Sarepta Therapeutics Latest Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Information
11.5.2 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product Offered
11.5.3 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Alnylam Pharmaceuticals Main Business Overview
11.5.5 Alnylam Pharmaceuticals Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Gene-based Therapy Medicinal Product Offered
11.6.3 Amgen Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Information
11.7.2 Spark Therapeutics Gene-based Therapy Medicinal Product Offered
11.7.3 Spark Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Spark Therapeutics Main Business Overview
11.7.5 Spark Therapeutics Latest Developments
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Information
11.8.2 Akcea Therapeutics Gene-based Therapy Medicinal Product Offered
11.8.3 Akcea Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Akcea Therapeutics Main Business Overview
11.8.5 Akcea Therapeutics Latest Developments
11.9 Sunway Biotech
11.9.1 Sunway Biotech Company Information
11.9.2 Sunway Biotech Gene-based Therapy Medicinal Product Offered
11.9.3 Sunway Biotech Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Sunway Biotech Main Business Overview
11.9.5 Sunway Biotech Latest Developments
11.10 SIBIONO
11.10.1 SIBIONO Company Information
11.10.2 SIBIONO Gene-based Therapy Medicinal Product Offered
11.10.3 SIBIONO Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 SIBIONO Main Business Overview
11.10.5 SIBIONO Latest Developments
11.11 AnGes
11.11.1 AnGes Company Information
11.11.2 AnGes Gene-based Therapy Medicinal Product Offered
11.11.3 AnGes Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 AnGes Main Business Overview
11.11.5 AnGes Latest Developments
11.12 Orchard Therapeutics
11.12.1 Orchard Therapeutics Company Information
11.12.2 Orchard Therapeutics Gene-based Therapy Medicinal Product Offered
11.12.3 Orchard Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Orchard Therapeutics Main Business Overview
11.12.5 Orchard Therapeutics Latest Developments
11.13 Human Stem Cells Institute
11.13.1 Human Stem Cells Institute Company Information
11.13.2 Human Stem Cells Institute Gene-based Therapy Medicinal Product Offered
11.13.3 Human Stem Cells Institute Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Human Stem Cells Institute Main Business Overview
11.13.5 Human Stem Cells Institute Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene-based Therapy Medicinal Market Size 2018-2029
2.1.2 Gene-based Therapy Medicinal Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Gene-based Therapy Medicinal Segment by Type
2.2.1 Viral Gene Delivery System
2.2.2 Non-viral Gene Delivery System
2.3 Gene-based Therapy Medicinal Market Size by Type
2.3.1 Gene-based Therapy Medicinal Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Gene-based Therapy Medicinal Market Size Market Share by Type (2018-2023)
2.4 Gene-based Therapy Medicinal Segment by Application
2.4.1 Neurological Diseases
2.4.2 Cancer
2.4.3 Other
2.5 Gene-based Therapy Medicinal Market Size by Application
2.5.1 Gene-based Therapy Medicinal Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Gene-based Therapy Medicinal Market Size Market Share by Application (2018-2023)
3 GENE-BASED THERAPY MEDICINAL MARKET SIZE BY PLAYER
3.1 Gene-based Therapy Medicinal Market Size Market Share by Players
3.1.1 Global Gene-based Therapy Medicinal Revenue by Players (2018-2023)
3.1.2 Global Gene-based Therapy Medicinal Revenue Market Share by Players (2018-2023)
3.2 Global Gene-based Therapy Medicinal Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE-BASED THERAPY MEDICINAL BY REGIONS
4.1 Gene-based Therapy Medicinal Market Size by Regions (2018-2023)
4.2 Americas Gene-based Therapy Medicinal Market Size Growth (2018-2023)
4.3 APAC Gene-based Therapy Medicinal Market Size Growth (2018-2023)
4.4 Europe Gene-based Therapy Medicinal Market Size Growth (2018-2023)
4.5 Middle East & Africa Gene-based Therapy Medicinal Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Gene-based Therapy Medicinal Market Size by Country (2018-2023)
5.2 Americas Gene-based Therapy Medicinal Market Size by Type (2018-2023)
5.3 Americas Gene-based Therapy Medicinal Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene-based Therapy Medicinal Market Size by Region (2018-2023)
6.2 APAC Gene-based Therapy Medicinal Market Size by Type (2018-2023)
6.3 APAC Gene-based Therapy Medicinal Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene-based Therapy Medicinal by Country (2018-2023)
7.2 Europe Gene-based Therapy Medicinal Market Size by Type (2018-2023)
7.3 Europe Gene-based Therapy Medicinal Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene-based Therapy Medicinal by Region (2018-2023)
8.2 Middle East & Africa Gene-based Therapy Medicinal Market Size by Type (2018-2023)
8.3 Middle East & Africa Gene-based Therapy Medicinal Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE-BASED THERAPY MEDICINAL MARKET FORECAST
10.1 Global Gene-based Therapy Medicinal Forecast by Regions (2024-2029)
10.1.1 Global Gene-based Therapy Medicinal Forecast by Regions (2024-2029)
10.1.2 Americas Gene-based Therapy Medicinal Forecast
10.1.3 APAC Gene-based Therapy Medicinal Forecast
10.1.4 Europe Gene-based Therapy Medicinal Forecast
10.1.5 Middle East & Africa Gene-based Therapy Medicinal Forecast
10.2 Americas Gene-based Therapy Medicinal Forecast by Country (2024-2029)
10.2.1 United States Gene-based Therapy Medicinal Market Forecast
10.2.2 Canada Gene-based Therapy Medicinal Market Forecast
10.2.3 Mexico Gene-based Therapy Medicinal Market Forecast
10.2.4 Brazil Gene-based Therapy Medicinal Market Forecast
10.3 APAC Gene-based Therapy Medicinal Forecast by Region (2024-2029)
10.3.1 China Gene-based Therapy Medicinal Market Forecast
10.3.2 Japan Gene-based Therapy Medicinal Market Forecast
10.3.3 Korea Gene-based Therapy Medicinal Market Forecast
10.3.4 Southeast Asia Gene-based Therapy Medicinal Market Forecast
10.3.5 India Gene-based Therapy Medicinal Market Forecast
10.3.6 Australia Gene-based Therapy Medicinal Market Forecast
10.4 Europe Gene-based Therapy Medicinal Forecast by Country (2024-2029)
10.4.1 Germany Gene-based Therapy Medicinal Market Forecast
10.4.2 France Gene-based Therapy Medicinal Market Forecast
10.4.3 UK Gene-based Therapy Medicinal Market Forecast
10.4.4 Italy Gene-based Therapy Medicinal Market Forecast
10.4.5 Russia Gene-based Therapy Medicinal Market Forecast
10.5 Middle East & Africa Gene-based Therapy Medicinal Forecast by Region (2024-2029)
10.5.1 Egypt Gene-based Therapy Medicinal Market Forecast
10.5.2 South Africa Gene-based Therapy Medicinal Market Forecast
10.5.3 Israel Gene-based Therapy Medicinal Market Forecast
10.5.4 Turkey Gene-based Therapy Medicinal Market Forecast
10.5.5 GCC Countries Gene-based Therapy Medicinal Market Forecast
10.6 Global Gene-based Therapy Medicinal Forecast by Type (2024-2029)
10.7 Global Gene-based Therapy Medicinal Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Gene-based Therapy Medicinal Product Offered
11.1.3 Biogen Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Biogen Main Business Overview
11.1.5 Biogen Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Gene-based Therapy Medicinal Product Offered
11.2.3 Novartis Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Information
11.3.2 Gilead Sciences Gene-based Therapy Medicinal Product Offered
11.3.3 Gilead Sciences Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Gilead Sciences Main Business Overview
11.3.5 Gilead Sciences Latest Developments
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Information
11.4.2 Sarepta Therapeutics Gene-based Therapy Medicinal Product Offered
11.4.3 Sarepta Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Sarepta Therapeutics Main Business Overview
11.4.5 Sarepta Therapeutics Latest Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Information
11.5.2 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product Offered
11.5.3 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Alnylam Pharmaceuticals Main Business Overview
11.5.5 Alnylam Pharmaceuticals Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Gene-based Therapy Medicinal Product Offered
11.6.3 Amgen Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Information
11.7.2 Spark Therapeutics Gene-based Therapy Medicinal Product Offered
11.7.3 Spark Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Spark Therapeutics Main Business Overview
11.7.5 Spark Therapeutics Latest Developments
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Information
11.8.2 Akcea Therapeutics Gene-based Therapy Medicinal Product Offered
11.8.3 Akcea Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Akcea Therapeutics Main Business Overview
11.8.5 Akcea Therapeutics Latest Developments
11.9 Sunway Biotech
11.9.1 Sunway Biotech Company Information
11.9.2 Sunway Biotech Gene-based Therapy Medicinal Product Offered
11.9.3 Sunway Biotech Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Sunway Biotech Main Business Overview
11.9.5 Sunway Biotech Latest Developments
11.10 SIBIONO
11.10.1 SIBIONO Company Information
11.10.2 SIBIONO Gene-based Therapy Medicinal Product Offered
11.10.3 SIBIONO Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 SIBIONO Main Business Overview
11.10.5 SIBIONO Latest Developments
11.11 AnGes
11.11.1 AnGes Company Information
11.11.2 AnGes Gene-based Therapy Medicinal Product Offered
11.11.3 AnGes Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 AnGes Main Business Overview
11.11.5 AnGes Latest Developments
11.12 Orchard Therapeutics
11.12.1 Orchard Therapeutics Company Information
11.12.2 Orchard Therapeutics Gene-based Therapy Medicinal Product Offered
11.12.3 Orchard Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Orchard Therapeutics Main Business Overview
11.12.5 Orchard Therapeutics Latest Developments
11.13 Human Stem Cells Institute
11.13.1 Human Stem Cells Institute Company Information
11.13.2 Human Stem Cells Institute Gene-based Therapy Medicinal Product Offered
11.13.3 Human Stem Cells Institute Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Human Stem Cells Institute Main Business Overview
11.13.5 Human Stem Cells Institute Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gene-based Therapy Medicinal Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Viral Gene Delivery System
Table 3. Major Players of Non-viral Gene Delivery System
Table 4. Gene-based Therapy Medicinal Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Gene-based Therapy Medicinal Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Gene-based Therapy Medicinal Market Size Market Share by Type (2018-2023)
Table 7. Gene-based Therapy Medicinal Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Gene-based Therapy Medicinal Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Gene-based Therapy Medicinal Market Size Market Share by Application (2018-2023)
Table 10. Global Gene-based Therapy Medicinal Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Gene-based Therapy Medicinal Revenue Market Share by Player (2018-2023)
Table 12. Gene-based Therapy Medicinal Key Players Head office and Products Offered
Table 13. Gene-based Therapy Medicinal Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Gene-based Therapy Medicinal Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Gene-based Therapy Medicinal Market Size Market Share by Regions (2018-2023)
Table 18. Global Gene-based Therapy Medicinal Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Gene-based Therapy Medicinal Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Gene-based Therapy Medicinal Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Gene-based Therapy Medicinal Market Size Market Share by Country (2018-2023)
Table 22. Americas Gene-based Therapy Medicinal Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Gene-based Therapy Medicinal Market Size Market Share by Type (2018-2023)
Table 24. Americas Gene-based Therapy Medicinal Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Gene-based Therapy Medicinal Market Size Market Share by Application (2018-2023)
Table 26. APAC Gene-based Therapy Medicinal Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Gene-based Therapy Medicinal Market Size Market Share by Region (2018-2023)
Table 28. APAC Gene-based Therapy Medicinal Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Gene-based Therapy Medicinal Market Size Market Share by Type (2018-2023)
Table 30. APAC Gene-based Therapy Medicinal Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Gene-based Therapy Medicinal Market Size Market Share by Application (2018-2023)
Table 32. Europe Gene-based Therapy Medicinal Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Gene-based Therapy Medicinal Market Size Market Share by Country (2018-2023)
Table 34. Europe Gene-based Therapy Medicinal Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Gene-based Therapy Medicinal Market Size Market Share by Type (2018-2023)
Table 36. Europe Gene-based Therapy Medicinal Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Gene-based Therapy Medicinal Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Gene-based Therapy Medicinal Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Gene-based Therapy Medicinal Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Gene-based Therapy Medicinal Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Gene-based Therapy Medicinal Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Gene-based Therapy Medicinal Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Gene-based Therapy Medicinal Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Gene-based Therapy Medicinal
Table 45. Key Market Challenges & Risks of Gene-based Therapy Medicinal
Table 46. Key Industry Trends of Gene-based Therapy Medicinal
Table 47. Global Gene-based Therapy Medicinal Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Gene-based Therapy Medicinal Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Gene-based Therapy Medicinal Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Gene-based Therapy Medicinal Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Biogen Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 52. Biogen Gene-based Therapy Medicinal Product Offered
Table 53. Biogen Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Biogen Main Business
Table 55. Biogen Latest Developments
Table 56. Novartis Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 57. Novartis Gene-based Therapy Medicinal Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Novartis Latest Developments
Table 61. Gilead Sciences Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 62. Gilead Sciences Gene-based Therapy Medicinal Product Offered
Table 63. Gilead Sciences Main Business
Table 64. Gilead Sciences Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Gilead Sciences Latest Developments
Table 66. Sarepta Therapeutics Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 67. Sarepta Therapeutics Gene-based Therapy Medicinal Product Offered
Table 68. Sarepta Therapeutics Main Business
Table 69. Sarepta Therapeutics Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Sarepta Therapeutics Latest Developments
Table 71. Alnylam Pharmaceuticals Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 72. Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product Offered
Table 73. Alnylam Pharmaceuticals Main Business
Table 74. Alnylam Pharmaceuticals Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Alnylam Pharmaceuticals Latest Developments
Table 76. Amgen Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 77. Amgen Gene-based Therapy Medicinal Product Offered
Table 78. Amgen Main Business
Table 79. Amgen Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Amgen Latest Developments
Table 81. Spark Therapeutics Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 82. Spark Therapeutics Gene-based Therapy Medicinal Product Offered
Table 83. Spark Therapeutics Main Business
Table 84. Spark Therapeutics Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Spark Therapeutics Latest Developments
Table 86. Akcea Therapeutics Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 87. Akcea Therapeutics Gene-based Therapy Medicinal Product Offered
Table 88. Akcea Therapeutics Main Business
Table 89. Akcea Therapeutics Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Akcea Therapeutics Latest Developments
Table 91. Sunway Biotech Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 92. Sunway Biotech Gene-based Therapy Medicinal Product Offered
Table 93. Sunway Biotech Main Business
Table 94. Sunway Biotech Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Sunway Biotech Latest Developments
Table 96. SIBIONO Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 97. SIBIONO Gene-based Therapy Medicinal Product Offered
Table 98. SIBIONO Main Business
Table 99. SIBIONO Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. SIBIONO Latest Developments
Table 101. AnGes Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 102. AnGes Gene-based Therapy Medicinal Product Offered
Table 103. AnGes Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. AnGes Main Business
Table 105. AnGes Latest Developments
Table 106. Orchard Therapeutics Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 107. Orchard Therapeutics Gene-based Therapy Medicinal Product Offered
Table 108. Orchard Therapeutics Main Business
Table 109. Orchard Therapeutics Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Orchard Therapeutics Latest Developments
Table 111. Human Stem Cells Institute Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 112. Human Stem Cells Institute Gene-based Therapy Medicinal Product Offered
Table 113. Human Stem Cells Institute Main Business
Table 114. Human Stem Cells Institute Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Human Stem Cells Institute Latest Developments
Table 1. Gene-based Therapy Medicinal Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Viral Gene Delivery System
Table 3. Major Players of Non-viral Gene Delivery System
Table 4. Gene-based Therapy Medicinal Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Gene-based Therapy Medicinal Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Gene-based Therapy Medicinal Market Size Market Share by Type (2018-2023)
Table 7. Gene-based Therapy Medicinal Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Gene-based Therapy Medicinal Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Gene-based Therapy Medicinal Market Size Market Share by Application (2018-2023)
Table 10. Global Gene-based Therapy Medicinal Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Gene-based Therapy Medicinal Revenue Market Share by Player (2018-2023)
Table 12. Gene-based Therapy Medicinal Key Players Head office and Products Offered
Table 13. Gene-based Therapy Medicinal Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Gene-based Therapy Medicinal Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Gene-based Therapy Medicinal Market Size Market Share by Regions (2018-2023)
Table 18. Global Gene-based Therapy Medicinal Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Gene-based Therapy Medicinal Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Gene-based Therapy Medicinal Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Gene-based Therapy Medicinal Market Size Market Share by Country (2018-2023)
Table 22. Americas Gene-based Therapy Medicinal Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Gene-based Therapy Medicinal Market Size Market Share by Type (2018-2023)
Table 24. Americas Gene-based Therapy Medicinal Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Gene-based Therapy Medicinal Market Size Market Share by Application (2018-2023)
Table 26. APAC Gene-based Therapy Medicinal Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Gene-based Therapy Medicinal Market Size Market Share by Region (2018-2023)
Table 28. APAC Gene-based Therapy Medicinal Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Gene-based Therapy Medicinal Market Size Market Share by Type (2018-2023)
Table 30. APAC Gene-based Therapy Medicinal Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Gene-based Therapy Medicinal Market Size Market Share by Application (2018-2023)
Table 32. Europe Gene-based Therapy Medicinal Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Gene-based Therapy Medicinal Market Size Market Share by Country (2018-2023)
Table 34. Europe Gene-based Therapy Medicinal Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Gene-based Therapy Medicinal Market Size Market Share by Type (2018-2023)
Table 36. Europe Gene-based Therapy Medicinal Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Gene-based Therapy Medicinal Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Gene-based Therapy Medicinal Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Gene-based Therapy Medicinal Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Gene-based Therapy Medicinal Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Gene-based Therapy Medicinal Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Gene-based Therapy Medicinal Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Gene-based Therapy Medicinal Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Gene-based Therapy Medicinal
Table 45. Key Market Challenges & Risks of Gene-based Therapy Medicinal
Table 46. Key Industry Trends of Gene-based Therapy Medicinal
Table 47. Global Gene-based Therapy Medicinal Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Gene-based Therapy Medicinal Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Gene-based Therapy Medicinal Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Gene-based Therapy Medicinal Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Biogen Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 52. Biogen Gene-based Therapy Medicinal Product Offered
Table 53. Biogen Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Biogen Main Business
Table 55. Biogen Latest Developments
Table 56. Novartis Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 57. Novartis Gene-based Therapy Medicinal Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Novartis Latest Developments
Table 61. Gilead Sciences Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 62. Gilead Sciences Gene-based Therapy Medicinal Product Offered
Table 63. Gilead Sciences Main Business
Table 64. Gilead Sciences Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Gilead Sciences Latest Developments
Table 66. Sarepta Therapeutics Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 67. Sarepta Therapeutics Gene-based Therapy Medicinal Product Offered
Table 68. Sarepta Therapeutics Main Business
Table 69. Sarepta Therapeutics Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Sarepta Therapeutics Latest Developments
Table 71. Alnylam Pharmaceuticals Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 72. Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product Offered
Table 73. Alnylam Pharmaceuticals Main Business
Table 74. Alnylam Pharmaceuticals Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Alnylam Pharmaceuticals Latest Developments
Table 76. Amgen Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 77. Amgen Gene-based Therapy Medicinal Product Offered
Table 78. Amgen Main Business
Table 79. Amgen Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Amgen Latest Developments
Table 81. Spark Therapeutics Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 82. Spark Therapeutics Gene-based Therapy Medicinal Product Offered
Table 83. Spark Therapeutics Main Business
Table 84. Spark Therapeutics Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Spark Therapeutics Latest Developments
Table 86. Akcea Therapeutics Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 87. Akcea Therapeutics Gene-based Therapy Medicinal Product Offered
Table 88. Akcea Therapeutics Main Business
Table 89. Akcea Therapeutics Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Akcea Therapeutics Latest Developments
Table 91. Sunway Biotech Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 92. Sunway Biotech Gene-based Therapy Medicinal Product Offered
Table 93. Sunway Biotech Main Business
Table 94. Sunway Biotech Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Sunway Biotech Latest Developments
Table 96. SIBIONO Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 97. SIBIONO Gene-based Therapy Medicinal Product Offered
Table 98. SIBIONO Main Business
Table 99. SIBIONO Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. SIBIONO Latest Developments
Table 101. AnGes Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 102. AnGes Gene-based Therapy Medicinal Product Offered
Table 103. AnGes Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. AnGes Main Business
Table 105. AnGes Latest Developments
Table 106. Orchard Therapeutics Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 107. Orchard Therapeutics Gene-based Therapy Medicinal Product Offered
Table 108. Orchard Therapeutics Main Business
Table 109. Orchard Therapeutics Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Orchard Therapeutics Latest Developments
Table 111. Human Stem Cells Institute Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 112. Human Stem Cells Institute Gene-based Therapy Medicinal Product Offered
Table 113. Human Stem Cells Institute Main Business
Table 114. Human Stem Cells Institute Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Human Stem Cells Institute Latest Developments
LIST OF FIGURES
Figure 1. Gene-based Therapy Medicinal Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene-based Therapy Medicinal Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Gene-based Therapy Medicinal Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Gene-based Therapy Medicinal Sales Market Share by Country/Region (2022)
Figure 8. Gene-based Therapy Medicinal Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Gene-based Therapy Medicinal Market Size Market Share by Type in 2022
Figure 10. Gene-based Therapy Medicinal in Neurological Diseases
Figure 11. Global Gene-based Therapy Medicinal Market: Neurological Diseases (2018-2023) & ($ Millions)
Figure 12. Gene-based Therapy Medicinal in Cancer
Figure 13. Global Gene-based Therapy Medicinal Market: Cancer (2018-2023) & ($ Millions)
Figure 14. Gene-based Therapy Medicinal in Other
Figure 15. Global Gene-based Therapy Medicinal Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Gene-based Therapy Medicinal Market Size Market Share by Application in 2022
Figure 17. Global Gene-based Therapy Medicinal Revenue Market Share by Player in 2022
Figure 18. Global Gene-based Therapy Medicinal Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Gene-based Therapy Medicinal Market Size 2018-2023 ($ Millions)
Figure 20. APAC Gene-based Therapy Medicinal Market Size 2018-2023 ($ Millions)
Figure 21. Europe Gene-based Therapy Medicinal Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Gene-based Therapy Medicinal Market Size 2018-2023 ($ Millions)
Figure 23. Americas Gene-based Therapy Medicinal Value Market Share by Country in 2022
Figure 24. United States Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Gene-based Therapy Medicinal Market Size Market Share by Region in 2022
Figure 29. APAC Gene-based Therapy Medicinal Market Size Market Share by Type in 2022
Figure 30. APAC Gene-based Therapy Medicinal Market Size Market Share by Application in 2022
Figure 31. China Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Gene-based Therapy Medicinal Market Size Market Share by Country in 2022
Figure 38. Europe Gene-based Therapy Medicinal Market Size Market Share by Type (2018-2023)
Figure 39. Europe Gene-based Therapy Medicinal Market Size Market Share by Application (2018-2023)
Figure 40. Germany Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Gene-based Therapy Medicinal Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Gene-based Therapy Medicinal Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Gene-based Therapy Medicinal Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 54. APAC Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 55. Europe Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 57. United States Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 58. Canada Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 61. China Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 62. Japan Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 63. Korea Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 65. India Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 66. Australia Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 67. Germany Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 68. France Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 69. UK Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 70. Italy Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 71. Russia Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 72. Spain Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 75. Israel Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 78. Global Gene-based Therapy Medicinal Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Gene-based Therapy Medicinal Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Gene-based Therapy Medicinal Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene-based Therapy Medicinal Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Gene-based Therapy Medicinal Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Gene-based Therapy Medicinal Sales Market Share by Country/Region (2022)
Figure 8. Gene-based Therapy Medicinal Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Gene-based Therapy Medicinal Market Size Market Share by Type in 2022
Figure 10. Gene-based Therapy Medicinal in Neurological Diseases
Figure 11. Global Gene-based Therapy Medicinal Market: Neurological Diseases (2018-2023) & ($ Millions)
Figure 12. Gene-based Therapy Medicinal in Cancer
Figure 13. Global Gene-based Therapy Medicinal Market: Cancer (2018-2023) & ($ Millions)
Figure 14. Gene-based Therapy Medicinal in Other
Figure 15. Global Gene-based Therapy Medicinal Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Gene-based Therapy Medicinal Market Size Market Share by Application in 2022
Figure 17. Global Gene-based Therapy Medicinal Revenue Market Share by Player in 2022
Figure 18. Global Gene-based Therapy Medicinal Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Gene-based Therapy Medicinal Market Size 2018-2023 ($ Millions)
Figure 20. APAC Gene-based Therapy Medicinal Market Size 2018-2023 ($ Millions)
Figure 21. Europe Gene-based Therapy Medicinal Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Gene-based Therapy Medicinal Market Size 2018-2023 ($ Millions)
Figure 23. Americas Gene-based Therapy Medicinal Value Market Share by Country in 2022
Figure 24. United States Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Gene-based Therapy Medicinal Market Size Market Share by Region in 2022
Figure 29. APAC Gene-based Therapy Medicinal Market Size Market Share by Type in 2022
Figure 30. APAC Gene-based Therapy Medicinal Market Size Market Share by Application in 2022
Figure 31. China Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Gene-based Therapy Medicinal Market Size Market Share by Country in 2022
Figure 38. Europe Gene-based Therapy Medicinal Market Size Market Share by Type (2018-2023)
Figure 39. Europe Gene-based Therapy Medicinal Market Size Market Share by Application (2018-2023)
Figure 40. Germany Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Gene-based Therapy Medicinal Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Gene-based Therapy Medicinal Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Gene-based Therapy Medicinal Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Gene-based Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 54. APAC Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 55. Europe Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 57. United States Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 58. Canada Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 61. China Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 62. Japan Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 63. Korea Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 65. India Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 66. Australia Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 67. Germany Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 68. France Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 69. UK Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 70. Italy Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 71. Russia Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 72. Spain Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 75. Israel Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Gene-based Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 78. Global Gene-based Therapy Medicinal Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Gene-based Therapy Medicinal Market Size Market Share Forecast by Application (2024-2029)
